INOVIQ (ASX: IIQ) has reported superior efficacy from an in vitro study of CAR-exosomes cancer therapy that killed almost 88% ...

The Calibr-Skaggs Institute for Innovative Medicines , the drug development division of Scripps Research, today announced a milestone in ...

Results show the regimen of epcoritamab plus R-ICE could serve most patients as a bridge to either autologous stem cell ...

GEO-CM04S1 Demonstrates Superior T Cell Responses Compared to mRNA Vaccine in Phase 2 Trial Among Immunocompromised Patients ...

SunRock Biopharma and Escugen have joined forces in a strategic partnership to co-develop SRB123, a First-in-Class ...

I n February 2025, it was revealed that a woman who as a child had undergone treatment for neuroblastoma was still ...

Phase 2 study, led by Dr. Antonio Jimeno at the University of Colorado Anschutz Medical Campus will evaluate NT219 in ...

A diagnosis of 4 stage ovarian cancer can be devastating. However, advances in medical science are helping patients and ...